Skip to main content
. 2019 Aug 29;366:l4772. doi: 10.1136/bmj.l4772

Fig 1.

Fig 1

Flowchart of patient inclusion in study cohort of new users of SGLT2 inhibitors and DPP4 inhibitors in Denmark, Norway, and Sweden, from April 2013 to December 2016. SGLT2=sodium-glucose cotransporter 2; DDP4=dipeptidyl peptidase 4. A single patient could be excluded because of more than one reason